Nemagen
1 known investors
Find your way into Nemagen
Sign up to see every warm intro you have to Nemagen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nemagen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
Founders & leadership
M
MarkAssociate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School
M
MartinChief Executive Officer
Investors · 1
Frequently asked questions
- What does Nemagen do?
- NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
- Who founded Nemagen?
- Nemagen was founded by Mark.
- Who are Nemagen's investors?
- Nemagen's investors include Foundation Venture Capital Group, LLC.
